XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Deficit (Details Narrative) - USD ($)
3 Months Ended
Feb. 25, 2021
Feb. 25, 2020
Jan. 02, 2020
Jan. 02, 2019
Jan. 02, 2017
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Stock options outstanding           5,673,861   5,597,861
Stock options outstanding weighted average exercise price   $ 5.60       $ 1.76    
Stock options intrinsic value           $ 23,025,089   $ 38,328
Number of stock options granted           366,000    
Stock option weighted average exercise price per share           $ 5.60    
Number of stock options vested           106,291    
Stock issued during the period exercised           10,000    
Class of warrant or right, outstanding           3,483,767   4,007,058
Common Stock [Member]                
Stock issued during the period exercised           10,000    
Warrants outstanding           240,123    
Proceeds from warrants exercised           $ 27,125    
Warrants [Member]                
Class of warrant or right, outstanding           3,483,767    
Class of warrant or right, outstanding, weighted average exercise price           $ 1.03    
Class of warrant or right, outstanding, intrinsic value           $ 16,684,157   $ 782,668
Warrants outstanding           373,042    
Options to Related Party [Member]                
Stock options outstanding           10,000    
Stock options outstanding weighted average exercise price           $ 1.00    
Stock issued during the period exercised           10,000    
Employees [Member]                
Compensation expense           $ 136,203    
Unamortized stock option expense           397,760    
Non-Employees [Member]                
Compensation expense           209,772    
Unamortized stock option expense           $ 2,380,966    
Five Individuals [Member]                
Number of stock options granted   366,000            
Stock Options [Member]                
Number of stock options granted           366,000 1,387,497  
Stock option weighted average exercise price per share             $ 5.60  
Compensation expense           $ 345,975 $ 360,436  
Stock Options [Member] | Options Vested Over 48 Months [Member]                
Number of stock options vested 16,000 350,000            
Stock Options [Member] | Settlement of Accrued Compensation [Member]                
Number of stock options granted   2,009,063            
Stock option weighted average exercise price per share   $ 5.60            
Stock Options [Member] | Five Individuals [Member]                
Number of stock options granted 366,000              
Stock Options [Member] | Related Parties [Member]                
Number of stock options granted   350,000            
Stock Options [Member] | General and Administrative Expense [Member]                
Compensation expense           344,499 325,794  
Stock Options [Member] | Research and Development Expenses [Member]                
Compensation expense           1,476 $ 34,641  
Stock Options [Member]                
Unamortized stock option expense           $ 2,778,726    
2016 Plan [Member]                
Number of additional shares grants for issuance     564,378 564,378 564,378      
Number of shares available for grant     1,693,134 1,693,134 1,693,134 4,868,623   4,868,623
Share-based payment award, expiration period           10 years